mhurhangee/ep-ind-claims huggingface dataset:
Interconnection element for connecting coils of the stator of a poly-phase rotating electrical machine, characterized in that it comprises a plurality of axially stacked conductive layers including a same number of solid annular base layers (26, 28, 30), and of additional layers (32, 34, 36), each formed by several ring parts, each of said ring parts not covering all of the perimeter of the stator, each of these conductive layers bearing internal connection lugs for connecting the coils and external connection lugs (48, 50) for connection to connected electrical equipment (4, 20), the number of base layers and the number of additional layers each being equal to the number of phases of the machine on which the interconnection element is added.
A process for manufacturing a polycarbonate, characterized in that it comprises: - a step of introducing, into a reactor, a composition comprising at least one dianhydrohexitol carbonate bearing two alkyl carbonate functions, said composition comprising, relative to the sum of plus: ▪ from 0 to 99.9% by weight and preferentially from 70% to 99.9% by weight of monomers of formula: ▪ and from 0.1% to 100% by weight and preferentially from 0.1% to 30% by weight of monomers of formula: and R1, R2, R3 and R4 being identical or different alkyl groups; - a step of introducing a diol or a mixture of diols; - a subsequent step of polycondensation by transesterification of the monomer mixture comprising, and optionally; - a step of recovering the polycarbonate formed in step; said polycarbonate recovered in step having a glass transition temperature greater than or equal to 25°C. - a step of introducing, into a reactor, a composition comprising at least one dianhydrohexitol carbonate bearing two alkyl carbonate functions, said composition comprising, relative to the sum of plus: ▪ from 0 to 99.9% by weight and preferentially from 70% to 99.9% by weight of monomers of formula: ▪ and from 0.1% to 100% by weight and preferentially from 0.1% to 30% by weight of monomers of formula: and R1, R2, R3 and R4 being identical or different alkyl groups; ▪ from 0 to 99.9% by weight and preferentially from 70% to 99.9% by weight of monomers of formula: ▪ and from 0.1% to 100% by weight and preferentially from 0.1% to 30% by weight of monomers of formula: and R1, R2, R3 and R4 being identical or different alkyl groups; - a step of introducing a diol or a mixture of diols; - a subsequent step of polycondensation by transesterification of the monomer mixture comprising, and optionally; - a step of recovering the polycarbonate formed in step; said polycarbonate recovered in step having a glass transition temperature greater than or equal to 25°C.
A parameter training method for a convolutional neural network, CNN, for classifying image type data representative of a single biometric trait, the method comprising the implementation, by data processing means of a server, of steps of: (a) For at least one data item from an already classified training database containing image type data representative of a single biometric trait, generating several alternate versions of this data item each by application of at least one geometric transformation chosen from a set of reference transformations satisfying a statistical distribution of geometric transformations observed in the training database, comprising the construction of a statistical atlas of the training data comprising an average model of images from the training database and also the variability of geometric transformations observed in the training database. (b) Training the parameters of said CNN, from the already classified training database augmented with said alternate versions of the data; wherein step (a) comprises substeps of: Statistical modeling of the transformations observed in said training database by means of said statistical atlas of training data; Determining said set of reference transformations satisfying a statistical distribution of transformations observed in the training database depending on the result of said statistical modeling. (a) For at least one data item from an already classified training database containing image type data representative of a single biometric trait, generating several alternate versions of this data item each by application of at least one geometric transformation chosen from a set of reference transformations satisfying a statistical distribution of geometric transformations observed in the training database, comprising the construction of a statistical atlas of the training data comprising an average model of images from the training database and also the variability of geometric transformations observed in the training database. (b) Training the parameters of said CNN, from the already classified training database augmented with said alternate versions of the data; Statistical modeling of the transformations observed in said training database by means of said statistical atlas of training data; Determining said set of reference transformations satisfying a statistical distribution of transformations observed in the training database depending on the result of said statistical modeling.
Interlock system for a vehicle comprising: - a sampler (4, 4') which is configured to collect an adequate sample of bodily fluids from a subject to be tested; - a readout unit (11, 11') couplable to the sampler (4, 4') for the detection of substances contained in the sample of bodily fluids; - a first evaluation unit (2, 2') couplable to the readout unit for evaluating the substances detected by the readout unit (11, 11'), in order to obtain concentrations for each of the substances detected; - wherein the detection and evaluation of substances in the bodily fluid takes place by means of chemical, immuno-chemical, enzymatic, electrochemical or optical detection methods, characterized by - a measurement assembly (8, 8') for the automatic measurement of measurement data which are a measure of the quantity of bodily fluid that has been collected from the subject, wherein the measurement assembly (8, 8') is configured to transmit the measurement data to a second evaluation unit (2, 2') and wherein the second evaluation unit (2, 2') is configured to determine by means of the measurement data whether the quantity of bodily fluid collected from the subject exceeds a predetermined threshold value; and - a control unit (1, 1') couplable to the first evaluation unit (2, 2') and the second evaluation unit (2a, 2a') which is configured to prevent the vehicle's starting sequence if the quantity of bodily fluid collected does not exceed the threshold value or if at least one of the substance concentrations is above or below a predetermined concentration threshold value. - a sampler (4, 4') which is configured to collect an adequate sample of bodily fluids from a subject to be tested; - a readout unit (11, 11') couplable to the sampler (4, 4') for the detection of substances contained in the sample of bodily fluids; - a first evaluation unit (2, 2') couplable to the readout unit for evaluating the substances detected by the readout unit (11, 11'), in order to obtain concentrations for each of the substances detected; - wherein the detection and evaluation of substances in the bodily fluid takes place by means of chemical, immuno-chemical, enzymatic, electrochemical or optical detection methods, characterized by - a measurement assembly (8, 8') for the automatic measurement of measurement data which are a measure of the quantity of bodily fluid that has been collected from the subject, wherein the measurement assembly (8, 8') is configured to transmit the measurement data to a second evaluation unit (2, 2') and wherein the second evaluation unit (2, 2') is configured to determine by means of the measurement data whether the quantity of bodily fluid collected from the subject exceeds a predetermined threshold value; and - a control unit (1, 1') couplable to the first evaluation unit (2, 2') and the second evaluation unit (2a, 2a') which is configured to prevent the vehicle's starting sequence if the quantity of bodily fluid collected does not exceed the threshold value or if at least one of the substance concentrations is above or below a predetermined concentration threshold value.
An in vitro method for designing a drug regime for an HIV-infected patient by determining the phenotypic susceptibility of HIV to at least one drug, comprising: i) using at least one sample comprising HIV RNA from a patient, wherein the sample comprises the complete HIV reverse transcriptase-integrase coding sequence; ii) reverse-transcribing and amplifying the HIV RNA with primers specific for the complete HIV reverse transcriptase-integrase coding sequence to obtain at least one amplicon comprising the complete HIV reverse transcriptase-integrase coding sequence, wherein at least one primer is selected from SEQ ID NO: 4-7; iii) generating a plasmid comprising a reference HIV sequence with a deletion of the complete HIV reverse transcriptase-integrase coding sequence; iv) preparing at least one recombinant virus by recombination or ligation between at least one amplicon obtained in step ii) and the plasmid comprising the reference HIV sequence with a deletion of the complete HIV reverse transcriptase-integrase coding sequence obtained in step iii), and v) monitoring at least one recombinant virus in the presence of at least one drug to determine the phenotypic susceptibility of HIV to at least one drug, wherein said susceptibility is determined by the cytopathogenicity of said recombinant virus to cells or by determining the replicative capacity of said recombinant virus in the presence of at least one drug. i) using at least one sample comprising HIV RNA from a patient, wherein the sample comprises the complete HIV reverse transcriptase-integrase coding sequence; ii) reverse-transcribing and amplifying the HIV RNA with primers specific for the complete HIV reverse transcriptase-integrase coding sequence to obtain at least one amplicon comprising the complete HIV reverse transcriptase-integrase coding sequence, wherein at least one primer is selected from SEQ ID NO: 4-7; iii) generating a plasmid comprising a reference HIV sequence with a deletion of the complete HIV reverse transcriptase-integrase coding sequence; iv) preparing at least one recombinant virus by recombination or ligation between at least one amplicon obtained in step ii) and the plasmid comprising the reference HIV sequence with a deletion of the complete HIV reverse transcriptase-integrase coding sequence obtained in step iii), and v) monitoring at least one recombinant virus in the presence of at least one drug to determine the phenotypic susceptibility of HIV to at least one drug,
Heat exchanger comprising a stack of plates comprising a lower plate onto which the other plates are stacked, and the heat exchanger comprises a fixation plate, and a reinforcement plate between the fixation plate and the lower plate, wherein the reinforcement plate has reinforcing elements only around one or more corners of the lower plate; characterized in that the fixation plate has a planar surface receiving the reinforcement plate and a protrusion around the reinforcement plate.
Method for determining a bias ( β i, j) affecting at least one pixel of a detector of ionizing radiation, the detector comprising a plurality of pixels (10 i,j), each pixel being configured to collect charge carriers generated by an interaction of the ionizing radiation in the detector, and to form a pulse under the effect of the generation and collection of the charge carriers, the pixels being distributed in a matrix array, the method comprising: a) following the occurrence of an interaction in the detector, at a detection time (t), determining at least one pixel forming a pulse that exceeds an amplitude threshold (A th) defined beforehand, during a detection time interval (dt) established on the basis of the detection time (t); b) among each pixel determined in step a), selecting the pixel that generates a highest amplitude (A max) during the detection time interval, the selected pixel being a pixel of interest (10 int); c) selecting at least one distant pixel (10 i,j - f), the position of the distant pixel, with respect to the pixel of interest (10 int), being defined beforehand, such that the effect of the interaction, detected by the pixel of interest, on the distant pixel, may be considered to be negligible; d) measuring an amplitude of a signal generated by each distant pixel in the detection time interval; e) on the basis of each measurement performed in step d), determining a bias ( β i,j ( t)) at the detection time for each distant pixel; f) updating a bias ( β i, j ( t), β i, j ( t)) affecting each distant pixel depending on the bias determined at the detection time. a) following the occurrence of an interaction in the detector, at a detection time (t), determining at least one pixel forming a pulse that exceeds an amplitude threshold (A th) defined beforehand, during a detection time interval (dt) established on the basis of the detection time (t); b) among each pixel determined in step a), selecting the pixel that generates a highest amplitude (A max) during the detection time interval, the selected pixel being a pixel of interest (10 int); c) selecting at least one distant pixel (10 i,j - f), the position of the distant pixel, with respect to the pixel of interest (10 int), being defined beforehand, such that the effect of the interaction, detected by the pixel of interest, on the distant pixel, may be considered to be negligible; d) measuring an amplitude of a signal generated by each distant pixel in the detection time interval; e) on the basis of each measurement performed in step d), determining a bias ( β i,j ( t)) at the detection time for each distant pixel; f) updating a bias ( β i, j ( t), β i, j ( t)) affecting each distant pixel depending on the bias determined at the detection time.
Personal electronic delivery unit, comprising: - a primary housing comprising an energy source and having a first end with an air inlet and a second end with a primary connector configured for connecting to a secondary housing configured for holding a cartridge with a delivery fluid and having an outlet or mouth piece; - a fluid path substantially extending between the air inlet and the outlet or mouth piece; - a heater element (30 that is provided in, at or close to the fluid path configured for heating the delivery fluid such that at least a part of a delivery fluid atomises and/or vaporises in the fluid path, wherein the heater element is in use connected to the energy source configured for providing energy to the heater element, and wherein the heater element is provided in and/or attached to the primary housing; and - a delivery fluid transfer element that is configured for transferring delivery fluid from the cartridge to the fluid path; and wherein the heater comprises a conductor and a porous ceramic layer that is configured to control the atomizing and/or vaporizing, characterised in that the ceramic layer is provided on or at the conductor with plasma electrolytic oxidation. - a primary housing comprising an energy source and having a first end with an air inlet and a second end with a primary connector configured for connecting to a secondary housing configured for holding a cartridge with a delivery fluid and having an outlet or mouth piece; - a fluid path substantially extending between the air inlet and the outlet or mouth piece; - a heater element (30 that is provided in, at or close to the fluid path configured for heating the delivery fluid such that at least a part of a delivery fluid atomises and/or vaporises in the fluid path, wherein the heater element is in use connected to the energy source configured for providing energy to the heater element, and wherein the heater element is provided in and/or attached to the primary housing; and - a delivery fluid transfer element that is configured for transferring delivery fluid from the cartridge to the fluid path; and
A method for producing hexafluoroacetone or a hydrate thereof, the method comprising subjecting a 1-fluoro-4,4-bis(trifluoromethyl)-2,3,5-trioxolanyl ether compound represented by the general formula: wherein R is an alkyl group having 1 to 8 carbon atoms, an aryl group, or a benzyl group, to a reduction reaction in the presence of an ozonide reducing agent selected from dipropyl sulfide, dibutyl sulfide, and diphenyl disulfide.
A medical device with an applicator for the targeted delivery or application of a liquid treatment medium with at least one medically active substance for an external treatment of a human or animal body to an area to be treated, with a pen-type applicator (1, 1a) from a reservoir which contains the treatment medium and which is provided with an application tip at one end thereof, via which the treatment medium can be applied to the area for treatment from the interior of the container by sweeping over said area with the applicator, wherein the at least one medically active substance is a substance for treating warts, characterized in that the application tip consists of a porous material, and the end (5.1) thereof that is used for applying the treatment medium has reduced porosity.
A method for jointly processing signals to be transmitted over respective ones of a plurality of subscriber lines (L 1 to L 4) through a non-linear precoder comprising a first non-linear precoding stage (301; 301') configured to operate according to a first triangular precoding matrix ( L; M; N) and including a modulo unit (Γ; γ), followed by a second linear precoding stage (302; 302') configured to operate according to a second precoding matrix ( Q; P), wherein the method comprises organizing the plurality of subscriber lines into a first group of subscriber lines (G A) and a second group of subscriber lines (G B), the first group of subscriber lines at least comprising the subscriber lines of the plurality of subscriber lines that do not support non-linear precoding operation (L2; L 4), and the second group of subscriber lines comprising the remaining subscriber lines of the plurality of subscriber lines (L 1; L3), scaling first signals ( U A) to be transmitted over respective ones of the first group of subscriber lines to confine respective first intermediate transmit power levels at the input of the modulo unit within a transmit power mask in order to bypass or make ineffective the operation of the modulo unit, processing the so scaled first signals ( U A ') through the first and second precoding stages, and processing second signals ( U B) to be transmitted over respective ones of the second group of subscriber lines through the first and second precoding stages.
A product comprising human derived follicle stimulating hormone for use in the treatment of infertility in a patient having serum AMH level of <15 pmol/L, wherein the product is to be administered at a dose of, or equivalent to, 11 to 13 μg human derived recombinant FSH per day, the human derived recombinant FSH including α2, 3- and α2, 6- sialylation wherein 30% to 60% of the total sialylation is α2, 3- sialyation, for example wherein 40% to 50% of the total sialylation is α2, 3- sialyation.
A base station for use in a wireless communication network comprising a relay station capable of relaying communications between the base station and a subscriber station, the base station comprising: a plurality of antennas; and a transmitter coupled to the plurality of antennas and configured to transmit, in a subframe, a plurality of transport blocks for a plurality of Hybrid Automatic Repeat Request, HARQ, processes to the relay station, wherein each transport block corresponds to a different HARQ process. a plurality of antennas; and a transmitter coupled to the plurality of antennas and configured to transmit, in a subframe, a plurality of transport blocks for a plurality of Hybrid Automatic Repeat Request, HARQ, processes to the relay station, wherein each transport block corresponds to a different HARQ process.
A plug for terminating a cable having four twisted pairs of insulated conductors comprising: (a) a housing having a cavity therein; (b) contacts for connection to the conductors and for connection to a socket into which the plug is to be received; and (c) a wire holder receivable into the cavity and having conductor-receiving paths extending there through for arranging the conductors between a first position where they are twisted and a second position at which they are untwisted and at which they are to be connected to the contacts, wherein the wire holder has - a base portion at said second position, the base portion having, for each conductor, conductor-receiving paths lying in substantially a single plane, - at least one wire-deflecting surface such that when the conductors are inserted into said paths, the conductors are forced to follow different directions, characterized in that, when the conductors are inserted into said paths and forced to follow different directions, the two conductors that will lie at the far left and the two at the far right in the base portion are following a linear path and the four conductors at the center are following a non-linear path to lie in a plane different of that of others of the conductors. - a base portion at said second position, the base portion having, for each conductor, conductor-receiving paths lying in substantially a single plane, - at least one wire-deflecting surface such that when the conductors are inserted into said paths, the conductors are forced to follow different directions, characterized in that, when the conductors are inserted into said paths and forced to follow different directions, the two conductors that will lie at the far left and the two at the far right in the base portion are following a linear path and the four conductors at the center are following a non-linear path to lie in a plane different of that of others of the conductors.
A thermoplastic resin composition comprising: 100 parts by weight of a polycarbonate resin; 1 to 30 parts by weight of a rubber-modified aromatic vinyl graft copolymer; 1 to 30 parts by weight of a polyester resin; 1 to 20 parts by weight a glycol-modified polyester resin having 10 mol% to 60 mol% of a cyclohexanedimethanol content based on a total amount of a diol component; and 0.5 to 15 parts by weight of a vinyl copolymer comprising an epoxy group, wherein a weight ratio of the polyester resin to the glycol-modified polyester resin ranges from 1:0.1 to 1:1. 100 parts by weight of a polycarbonate resin; 1 to 30 parts by weight of a rubber-modified aromatic vinyl graft copolymer; 1 to 30 parts by weight of a polyester resin; 1 to 20 parts by weight a glycol-modified polyester resin having 10 mol% to 60 mol% of a cyclohexanedimethanol content based on a total amount of a diol component; and 0.5 to 15 parts by weight of a vinyl copolymer comprising an epoxy group,